93 related articles for article (PubMed ID: 24284522)
1. Prevention of lipopolysaccharide-induced peritoneal damage by eplerenone in rats undergoing peritoneal dialysis.
Tayama Y; Hasegawa H; Takayanagi K; Matsuda A; Shimizu T; Asakura J; Iwashita T; Ogawa T; Katoh H; Mitarai T
J Nephrol; 2013; 26(6):1160-9. PubMed ID: 24284522
[TBL] [Abstract][Full Text] [Related]
2. The aldosterone receptor antagonist spironolactone prevents peritoneal inflammation and fibrosis.
Zhang L; Hao JB; Ren LS; Ding JL; Hao LR
Lab Invest; 2014 Aug; 94(8):839-50. PubMed ID: 24862968
[TBL] [Abstract][Full Text] [Related]
3. Role of rosiglitazone in lipopolysaccharide-induced peritonitis: a rat peritoneal dialysis model.
Song SH; Kwak IS; Yang BY; Lee DW; Lee SB; Lee MY
Nephrology (Carlton); 2009 Apr; 14(2):155-63. PubMed ID: 19207869
[TBL] [Abstract][Full Text] [Related]
4. Functional and structural alterations of peritoneum and secretion of fibrotic cytokines in rats caused by high glucose peritoneal dialysis solutions.
Liu Y; Li JF; Liu H; Liu FY; Peng YM; Liu YH; Cheng MC; Chen GC; Zhou X
Ren Fail; 2014 Mar; 36(2):292-9. PubMed ID: 24152223
[TBL] [Abstract][Full Text] [Related]
5. Hydrogen Sulfide Alleviates Peritoneal Fibrosis via Attenuating Inflammation and TGF-β1 Synthesis.
Lu Y; Gao L; Li L; Zhu Y; Wang Z; Shen H; Song K
Nephron; 2015; 131(3):210-9. PubMed ID: 26529331
[TBL] [Abstract][Full Text] [Related]
6. Mineralocorticoid receptor blockade ameliorates peritoneal fibrosis in new rat peritonitis model.
Nishimura H; Ito Y; Mizuno M; Tanaka A; Morita Y; Maruyama S; Yuzawa Y; Matsuo S
Am J Physiol Renal Physiol; 2008 May; 294(5):F1084-93. PubMed ID: 18353870
[TBL] [Abstract][Full Text] [Related]
7. L-2-oxothiazolidine-4-carboxylate: an agent that modulates lipopolysaccharide-induced peritonitis in rats.
Korybalska K; Wieczorowska-Tobis K; Polubinska A; Wisniewska J; Moberly J; Martis L; Breborowicz A; Oreopoulos DG
Perit Dial Int; 2002; 22(3):293-300. PubMed ID: 12227385
[TBL] [Abstract][Full Text] [Related]
8. PPAR-γ agonist rosiglitazone ameliorates peritoneal deterioration in peritoneal dialysis rats with LPS-induced peritonitis through up-regulation of AQP-1 and ZO-1.
Zhang Y; Feng J; Wang Q; Zhao S; Xu J; Li H
Biosci Rep; 2018 Jun; 38(3):. PubMed ID: 29871973
[TBL] [Abstract][Full Text] [Related]
9. Effects of low glucose degradation products peritoneal dialysis fluid on the peritoneal fibrosis and vascularization in a chronic rat model.
Kim CD; Kwon HM; Park SH; Oh EJ; Kim MH; Choi SY; Choi MJ; Kim IS; Park MS; Kim YJ; Kim YL
Ther Apher Dial; 2007 Feb; 11(1):56-64. PubMed ID: 17309576
[TBL] [Abstract][Full Text] [Related]
10. [High glucose dialysate enhances peritoneal fibrosis through upregulating glucose transporters GLUT1 and SGLT1].
Hong M; Nie Z; Chen Z; Yu X; Bao B
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2016 May; 45(6):598-606. PubMed ID: 28247603
[TBL] [Abstract][Full Text] [Related]
11. Pyridoxal phosphate and hepatocyte growth factor prevent dialysate-induced peritoneal damage.
Nakamura S; Niwa T
J Am Soc Nephrol; 2005 Jan; 16(1):144-50. PubMed ID: 15563557
[TBL] [Abstract][Full Text] [Related]
12. Calcitriol decreases TGF-β1 and angiotensin II production and protects against chlorhexide digluconate-induced liver peritoneal fibrosis in rats.
Lee CJ; Subeq YM; Lee RP; Liou HH; Hsu BG
Cytokine; 2014 Jan; 65(1):105-18. PubMed ID: 24210651
[TBL] [Abstract][Full Text] [Related]
13. Acute inflammation in peritoneal dialysis: experimental studies in rats. Characterization of regulatory mechanisms.
Bazargani F
Swed Dent J Suppl; 2005; (171):1-57, i. PubMed ID: 15847249
[TBL] [Abstract][Full Text] [Related]
14. Cyclooxygenase-2 and vascular endothelial growth factor expressions are involved in ultrafiltration failure.
Guo J; Xiao J; Gao H; Jin Y; Zhao Z; Jiao W; Liu Z; Zhao Z
J Surg Res; 2014 May; 188(2):527-536.e2. PubMed ID: 24559584
[TBL] [Abstract][Full Text] [Related]
15. Preservation of peritoneal morphology and function by pentoxifylline in a rat model of peritoneal dialysis: molecular studies.
Hung KY; Huang JW; Chiang CK; Tsai TJ
Nephrol Dial Transplant; 2008 Dec; 23(12):3831-40. PubMed ID: 18614818
[TBL] [Abstract][Full Text] [Related]
16. The role of the TGF/Smad signaling pathway in peritoneal fibrosis induced by peritoneal dialysis solutions.
Yao Q; Pawlaczyk K; Ayala ER; Styszynski A; Breborowicz A; Heimburger O; Qian JQ; Stenvinkel P; Lindholm B; Axelsson J
Nephron Exp Nephrol; 2008; 109(2):e71-8. PubMed ID: 18600031
[TBL] [Abstract][Full Text] [Related]
17. [The role of TGF-beta1/Smads in the development of peritoneal fibrosis induced by high glucose peritoneal dialysate and LPS].
Dou XR; Yu XQ; Li XY; Chen WF; Hao WK; Jia ZJ; Peng WX; Wang X; Yin PD; Wang WJ; Zheng ZH
Zhonghua Yi Xue Za Zhi; 2005 Sep; 85(37):2613-8. PubMed ID: 16321321
[TBL] [Abstract][Full Text] [Related]
18. Octreotide lessens peritoneal injury in experimental encapsulated peritoneal sclerosis model.
Ertilav M; Hur E; Bozkurt D; Sipahi S; Timur O; Sarsik B; Akcicek F; Duman S
Nephrology (Carlton); 2011 Aug; 16(6):552-7. PubMed ID: 21382127
[TBL] [Abstract][Full Text] [Related]
19. Valsartan decreases TGF-β1 production and protects against chlorhexidine digluconate-induced liver peritoneal fibrosis in rats.
Subeq YM; Ke CY; Lin NT; Lee CJ; Chiu YH; Hsu BG
Cytokine; 2011 Feb; 53(2):223-30. PubMed ID: 21129996
[TBL] [Abstract][Full Text] [Related]
20. Zymosan, but not lipopolysaccharide, triggers severe and progressive peritoneal injury accompanied by complement activation in a rat peritonitis model.
Mizuno M; Ito Y; Hepburn N; Mizuno T; Noda Y; Yuzawa Y; Harris CL; Morgan BP; Matsuo S
J Immunol; 2009 Jul; 183(2):1403-12. PubMed ID: 19553534
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
